- Markets
- Healthcare
- NATCAPSUQ
NATCAPSUQ
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Natural Capsules To Consider Raising Funds Via Issue Of Equity Shares
July 23 (Reuters) - Natural Capsules Ltd NACP.BO:
NATURAL CAPSULES - TO CONSIDER RAISING FUNDS VIA ISSUE OF EQUITY SHARES
Source text for Eikon: ID:nBSE9pGRNK
Further company coverage: NACP.BO
(([email protected];))
July 23 (Reuters) - Natural Capsules Ltd NACP.BO:
NATURAL CAPSULES - TO CONSIDER RAISING FUNDS VIA ISSUE OF EQUITY SHARES
Source text for Eikon: ID:nBSE9pGRNK
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules Reappoints Sunil L Mundra As MD
May 21 (Reuters) - Natural Capsules Ltd NACP.BO:
NATURAL CAPSULES LTD - REAPPOINTED SUNIL L MUNDRA AS MANAGING DIRECTOR
Source text for Eikon: ID:nBSE9lGnQ5
Further company coverage: NACP.BO
(([email protected];;))
May 21 (Reuters) - Natural Capsules Ltd NACP.BO:
NATURAL CAPSULES LTD - REAPPOINTED SUNIL L MUNDRA AS MANAGING DIRECTOR
Source text for Eikon: ID:nBSE9lGnQ5
Further company coverage: NACP.BO
(([email protected];;))
Natural Capsules Commences Commercial Production In High Speed Hpmc Line On March 18
March 18 (Reuters) - Natural Capsules Ltd NACP.BO:
COMMENCEMENT OF COMMERCIAL PRODUCTION IN HIGH SPEED HPMC LINE STARTING MARCH 18
Further company coverage: NACP.BO
(([email protected];))
March 18 (Reuters) - Natural Capsules Ltd NACP.BO:
COMMENCEMENT OF COMMERCIAL PRODUCTION IN HIGH SPEED HPMC LINE STARTING MARCH 18
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules' Unit Has Commenced Production Of Small Volume Batches On March 15
March 15 (Reuters) - Natural Capsules Ltd NACP.BO:
UNIT HAS COMMENCED PRODUCTION OF SMALL VOLUME BATCHES ON MARCH 15
Further company coverage: NACP.BO
(([email protected];))
March 15 (Reuters) - Natural Capsules Ltd NACP.BO:
UNIT HAS COMMENCED PRODUCTION OF SMALL VOLUME BATCHES ON MARCH 15
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules Entered Into Security Subscription And Shareholders' Agreement For Consumption And Supply Of Renewable Energy With O2 Energy SG PTE
Dec 29 (Reuters) - Natural Capsules Ltd NACP.BO:
ENTERED INTO SECURITY SUBSCRIPTION AND SHAREHOLDERS' AGREEMENT FOR CONSUMPTION AND SUPPLY OF RENEWABLE ENERGY WITH O2 ENERGY SG PTE
EXECUTED AN AMENDMENT TO AGREEMENT FOR PRUCHASE OF RENEWABLE ENERGY TO 10.66MW CAPACITY FROM SPV
SUBSCRIPTION FOR PURCHASE OF RENEWABLE ENERGY EQUIVALENT TO 5.33MW CAPACITY
Source text for Eikon: ID:nBSE9pm64d
Further company coverage: NACP.BO
(([email protected];))
Dec 29 (Reuters) - Natural Capsules Ltd NACP.BO:
ENTERED INTO SECURITY SUBSCRIPTION AND SHAREHOLDERS' AGREEMENT FOR CONSUMPTION AND SUPPLY OF RENEWABLE ENERGY WITH O2 ENERGY SG PTE
EXECUTED AN AMENDMENT TO AGREEMENT FOR PRUCHASE OF RENEWABLE ENERGY TO 10.66MW CAPACITY FROM SPV
SUBSCRIPTION FOR PURCHASE OF RENEWABLE ENERGY EQUIVALENT TO 5.33MW CAPACITY
Source text for Eikon: ID:nBSE9pm64d
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules Announces Strategic Investment By Somerset Indus Capital Partners
June 22 (Reuters) - Natural Capsules Ltd NACP.BO:
ANNOUNCES STRATEGIC INVESTMENT BY SOMERSET INDUS CAPITAL PARTNERS
SOMERSET INDUS CAPITAL PARTNERS INVESTED ABOUT 750 MILLION RUPEES AT PRE-MONEY VALUATION OF 2.50 BILLION RUPEES IN CO
SOMERSET INDUS CAPITAL PARTNERS WILL HOLD A STAKE BETWEEN 23% AND 28% IN NBPL
Source text for Eikon: ID:nBSE9SwGkh
Further company coverage: NACP.BO
(([email protected];))
June 22 (Reuters) - Natural Capsules Ltd NACP.BO:
ANNOUNCES STRATEGIC INVESTMENT BY SOMERSET INDUS CAPITAL PARTNERS
SOMERSET INDUS CAPITAL PARTNERS INVESTED ABOUT 750 MILLION RUPEES AT PRE-MONEY VALUATION OF 2.50 BILLION RUPEES IN CO
SOMERSET INDUS CAPITAL PARTNERS WILL HOLD A STAKE BETWEEN 23% AND 28% IN NBPL
Source text for Eikon: ID:nBSE9SwGkh
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules Says Somerset Indus Healthcare Fund II Invests 313.8 Million Rupees In Unit
June 9 (Reuters) - Natural Capsules Ltd NACP.BO:
SOMERSET INDUS HEALTHCARE FUND II INVESTED 313.8 MILLION RUPEES IN UNIT NATURAL BIOGENEX
Source text for Eikon: ID:nBSE9GCb21
Further company coverage: NACP.BO
(([email protected];))
June 9 (Reuters) - Natural Capsules Ltd NACP.BO:
SOMERSET INDUS HEALTHCARE FUND II INVESTED 313.8 MILLION RUPEES IN UNIT NATURAL BIOGENEX
Source text for Eikon: ID:nBSE9GCb21
Further company coverage: NACP.BO
(([email protected];))
Natural Capsules Declares Dividend 1 Rupees Per Share
May 26 (Reuters) - Natural Capsules Ltd NACP.BO:
DIVIDEND 1 RUPEES PER SHARE
Source text for Eikon: ID:nBSEblfd9R
Further company coverage: NACP.BO
(([email protected];))
May 26 (Reuters) - Natural Capsules Ltd NACP.BO:
DIVIDEND 1 RUPEES PER SHARE
Source text for Eikon: ID:nBSEblfd9R
Further company coverage: NACP.BO
(([email protected];))
Events:
Dividend
Dividend
Rights
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Natural Capsules do?
Natural Capsules Limited is a public limited company with modern manufacturing plants in Bangalore and Pondicherry. It specializes in producing hard gelatin and cellulose capsule shells, meeting cGMP and cGLP standards, and providing turnkey solutions.
Who are the competitors of Natural Capsules?
Natural Capsules major competitors are Coral Laboratories, Alpa Lab, Pharmaids Pharma, Sat Kartar Shopping, Oxygenta Pharma, Kimia Biosciences, Panchsheel Organics. Market Cap of Natural Capsules is ₹232 Crs. While the median market cap of its peers are ₹233 Crs.
Is Natural Capsules financially stable compared to its competitors?
Natural Capsules seems to be less financially stable compared to its competitors. Altman Z score of Natural Capsules is 2.15 and is ranked 6 out of its 8 competitors.
Does Natural Capsules pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Natural Capsules latest dividend payout ratio is 5.03% and 3yr average dividend payout ratio is 5.07%
How has Natural Capsules allocated its funds?
Companies resources are allocated to majorly unproductive assets like Capital Work in Progress
How strong is Natural Capsules balance sheet?
Balance sheet of Natural Capsules is moderately strong.
Is the profitablity of Natural Capsules improving?
No, profit is decreasing. The profit of Natural Capsules is ₹1.06 Crs for TTM, ₹5.55 Crs for Mar 2024 and ₹18.45 Crs for Mar 2023.
Is the debt of Natural Capsules increasing or decreasing?
Yes, The debt of Natural Capsules is increasing. Latest debt of Natural Capsules is ₹84.18 Crs as of Sep-24. This is greater than Mar-24 when it was ₹82.32 Crs.
Is Natural Capsules stock expensive?
Yes, Natural Capsules is expensive. Latest PE of Natural Capsules is 218, while 3 year average PE is 40.77. Also latest EV/EBITDA of Natural Capsules is 18.33 while 3yr average is 14.28.
Has the share price of Natural Capsules grown faster than its competition?
Natural Capsules has given better returns compared to its competitors. Natural Capsules has grown at ~14.8% over the last 8yrs while peers have grown at a median rate of 12.0%
Is the promoter bullish about Natural Capsules?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 51.21% and last quarter promoter holding is 51.14%.
Are mutual funds buying/selling Natural Capsules?
There is Insufficient data to gauge this.